NRx Pharmaceuticals Inc. (NRXP)
NASDAQ: NRXP
· Real-Time Price · USD
2.88
0.21 (7.87%)
At close: Aug 15, 2025, 3:59 PM
2.87
-0.34%
After-hours: Aug 15, 2025, 07:40 PM EDT
NRx Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -5.51M | -9.08M | -1.62M | -7.9M | -6.53M | -4.33M | -6.06M | -8.72M | -11.04M | -10.24M | -9.08M | -6.98M | -13.45M | -30.79M | -20.77M | -16.01M | -25.49M |
Depreciation & Amortization | 7K | 1K | 2K | 1K | 1K | 1K | 2K | 1K | 1K | 1K | 1K | 1K | 1K | 395.00 | 638.00 | 967.00 | n/a |
Stock-Based Compensation | 12K | 43K | 104K | 97K | 242K | -1.2M | 351K | 544K | 695K | 766K | 541K | 987K | 1.33M | 1.57M | 1.56M | 4.28M | 372K |
Other Working Capital | n/a | 10.08M | -697K | 929K | 196K | 1.42M | -713K | 1M | -1.7M | 762K | 3.15M | -4.97M | 3.37M | 1.75M | 8.95M | -16.94M | -1.21M |
Other Non-Cash Items | n/a | 7.07M | -728K | 2.19M | -1.52M | -2.28M | 359K | 913K | 1.76M | 486K | 37K | -2.6M | -2.26M | 18.88M | 8.34M | 5.21M | 21.25M |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 2.2M | -26K | 11K | n/a | n/a | n/a | n/a | n/a | 0.00 | 260.24K | -1.47M | n/a |
Change in Working Capital | n/a | -86K | 43K | 3.05M | 2.29M | 2.42M | 812K | -564K | 2.49M | 670K | 2.24M | -6.2M | 3.99M | -937.76K | -1.4M | -3.41M | 852K |
Operating Cash Flow | -3.48M | -2.1M | -2.31M | -3.5M | -3.67M | -3.19M | -4.56M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.01M | -11.39M | -3.02M |
Capital Expenditures | n/a | n/a | n/a | n/a | n/a | 4K | -2K | 2K | -4K | 1K | -5K | -3K | -3K | -388 | -3.83K | -2.78K | n/a |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | -3K | n/a | n/a | n/a | -10K | n/a | n/a | n/a | -7K | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | -3K | n/a | n/a | -4K | 10K | n/a | n/a | -3K | 32.78K | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | n/a | n/a | n/a | 1K | -2K | 2K | -4K | 1K | -5K | -3K | -3K | -388 | -3.83K | -2.78K | n/a |
Debt Repayment | n/a | 884K | -224K | -1K | -2.15M | -1.12M | -2.67M | 696K | n/a | 10.02M | n/a | n/a | n/a | 474.00 | -176.47K | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 4.33M | 1.01M | 2.06M | n/a | n/a | n/a | n/a | n/a | n/a | 102K | n/a | -518K | n/a | -117 | n/a | 9.95M | 7.5M |
Financial Cash Flow | 7.58M | 1.9M | 2.05M | 3.14M | 395K | -1.12M | -1.5M | 6.27M | 2.54M | 10.12M | -28K | -860K | 22.98M | 1.24K | 37.52M | 11.51M | 14.43M |
Net Cash Flow | 4.11M | -203K | -252K | 579K | -3.28M | -4.31M | -6.07M | -1.54M | -3.55M | 1.8M | -6.3M | -15.65M | 12.6M | -11.28M | 25.5M | 115.33K | 11.41M |
Free Cash Flow | -3.48M | -2.1M | -2.31M | -3.5M | -3.67M | -3.19M | -4.57M | -7.81M | -6.09M | -8.32M | -6.27M | -14.79M | -10.38M | -11.28M | -12.02M | -11.4M | -3.02M |